Identification of Pharmacophoric Fragments of DYRK1A Inhibitors Using Machine Learning Classification Models
Open Access
Abstract
Dual-specific tyrosine phosphorylation regulated kinase 1 (DYRK1A) has been regarded as a potential therapeutic target of neurodegenerative diseases, and considerable progress has been made in the discovery of DYRK1A inhibitors. Identification of pharmacophoric fragments provides valuable information for structure- and fragment-based design of potent and selective DYRK1A inhibitors. In this study, seven machine learning methods along with five molecular fingerprints were employed to develop qualitative classification models of DYRK1A inhibitors, which were evaluated by cross-validation, test set, and external validation set with four performance indicators of predictive classification accuracy (CA), the area under receiver operating characteristic (AUC), Matthews correlation coefficient (MCC), and balanced accuracy (BA). The PubChem fingerprint-support vector machine model (CA = 0.909, AUC = 0.933, MCC = 0.717, BA = 0.855) and PubChem fingerprint along with the artificial neural model (CA = 0.862, AUC = 0.911, MCC = 0.705, BA = 0.870) were considered as the optimal modes for training set and test set, respectively. A hybrid data balancing method SMOTETL, a combination of synthetic minority over-sampling technique (SMOTE) and Tomek link (TL) algorithms, was applied to explore the impact of balanced learning on the performance of models. Based on the frequency analysis and information gain, pharmacophoric fragments related to DYRK1A inhibition were also identified. All the results will provide theoretical supports and clues for the screening and design of novel DYRK1A inhibitors.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7222016)
- Research Foundation of Capital Institute of Pediatrics (CXYJ-2021-03)
- National Natural Science Foundation of China (82003599)
This publication has 37 references indexed in Scilit:
- QSAR and Pharmacophore Study of Dyrk1A Inhibitory Meridianin Analogs as Potential Agents for Treatment of Neurodegenerative DiseasesMedicinal Chemistry, 2013
- Two New Parameters Based on Distances in a Receiver Operating Characteristic Chart for the Selection of Classification ModelsJournal of Chemical Information and Modeling, 2011
- Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin DerivativesJournal of Medicinal Chemistry, 2011
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)Archives of Biochemistry and Biophysics, 2011
- PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprintsJournal of Computational Chemistry, 2010
- Activation, regulation, and inhibition of DYRK1AThe FEBS Journal, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brainEuropean Journal of Pharmacology, 2005
- A study of the behavior of several methods for balancing machine learning training dataACM SIGKDD Explorations Newsletter, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002